ArticleFrontiers in immunology2018

Immunoproteasome Inhibition Impairs T and B Cell Activation by Restraining ERK Signaling and Proteostasis.

Christian Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.